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AMP-activated protein kinase (AMPK) is activated
when the AMP/ATP ratio in cells is elevated due
to energy stress. Here, we describe a biosensor,
AMPKAR, that exhibits enhanced fluorescence
resonance energy transfer (FRET) in response to
phosphorylation by AMPK, allowing spatiotemporal
monitoring of AMPK activity in single cells. We
show that this reporter responds to a variety of
stimuli that are known to induce energy stress and
that the response is dependent on AMPK a1 and a2
and on the upstream kinase LKB1. Interestingly, we
found that AMPK activation is confined to the cytosol
in response to energy stress but can be observed in
both the cytosol and nucleus in response to calcium
elevation. Finally, using this probe with U2OS cells in
a microfluidic device, we observed a very high cell-
to-cell variability in the amplitude and time course
of AMPK activation and recovery in response to
pulses of glucose deprivation.INTRODUCTION
AMP-activated protein kinase (AMPK), an evolutionarily
conserved metabolic gauge, serves as an energy stress sensor
and a homeostatic regulator of cellular ATP levels (Hardie,
2007; Kahn et al., 2005; Lage et al., 2008; Steinberg and
Kemp, 2009). This serine/threonine protein kinase exists as a
heterotrimeric complex consisting of a catalytic a subunit and
regulatory b and g subunits each encoded by multiple genes
(Stapleton et al., 1996; Woods et al., 1996). Recent studies
have identified LKB1 and Ca2+/calmodulin-dependent protein
kinase kinase-beta (CaMKKb) as upstream kinases that phos-
phorylate Thr-172 in the activation loop of the catalytic subunit
to activate AMPK (Hawley et al., 2005; Hurley et al., 2005;
Shaw et al., 2004; Woods et al., 2005). It has been proposed
that the AMP binding to the regulatory g subunit enhances phos-
phorylation by LKB1 while cellular calcium levels affect CaMKKb476 Cell Metabolism 13, 476–486, April 6, 2011 ª2011 Elsevier Inc.dependent phosphorylation (Hawley et al., 2005; Hurley et al.,
2005; Woods et al., 2005; Woods et al., 2003). Recently, Oakhill
et al. have elegantly demonstrated that AMP directly stimulates
a-Thr172 phosphorylation provided the AMPK b-subunit is
myristoylated (Oakhill et al., 2010). AMP binding to AMPK also
renders it less susceptible to dephosphorylation at Thr-172 by
protein phosphatases (Sanders et al., 2007; Suter et al., 2006).
Once activated, AMPK stimulates catabolic pathways that
generate ATP, while inhibiting ATP-consuming processes such
as biosynthesis and cell growth and proliferation (Hardie, 2007;
Kahn et al., 2005).
Recently AMPK has been shown to play a central role in the
regulation of body weight, systemic glucose homeostasis, lipid
metabolism, and mitochondrial biogenesis, thus making it an
attractive therapeutic target (Fogarty and Hardie, 2010; Kahn
et al., 2005). In addition, AMPK also plays a crucial role in inhib-
iting many processes important for tumor development,
including cell-cycle progression, protein synthesis, and cell
growth, suggesting that AMPK activators could be used to
prevent or treat cancers (Fay et al., 2009) (Engelman and Cant-
ley, 2010).
In order to monitor the activation state of AMPK in cells and
tissues, antibodies have been raised against phosphopeptides
based on the sequence around Thr-172 of AMPK-a. These
antibodies, along with antibodies that specifically recognize
phosphorylated states of AMPK substrates, have been valuable
for monitoring AMPK in western blots following cell lysis.
However, current biochemical techniques do not allow for the
measurement of AMPK signaling in real time in live cells. As
a consequence, little is known about the location of AMPK acti-
vation in response to various stimuli or about the single-cell
variability in AMPK activation. These questions are important
since the upstream activator LKB1 can, under certain conditions,
localize in the nucleus (Dorfman and Macara, 2008) and since
some AMPK substrates are involved in gene regulation (McGee
and Hargreaves, 2008; Shaw et al., 2005).
Here, we describe the design and application of an AMPK
activity reporter (AMPKAR). Using AMPKAR, we were able to
detect endogenous AMPK activity in real time in live cells. This
reporter reveals differences in the subcellular localization, as
well as temporal dynamics of AMPK activation through two
different upstream kinases, LKB1 and CaMKKb. Interestingly,
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Figure 1. Schematic Representation of AMPKAR Construct
(A) Phosphorylation of the optimized AMPK substrate motif on AMPKAR
induces binding to the intrinsic FHA domain, thereby prompting a conforma-
tional change that is detected by a change in fluorescence resonance energy
transfer (FRET) between eCFP and an YFP variant Venus.
(B) Domain structures of AMPKAR and amino acid sequence of the optimized
AMPK substrate motif.
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A Cellular Energy Stress Sensorusing this probe, we also observed cell-cell variations in
response to energy stress. We found that there was a wide
variation in the response of individual U2OS cells to acute ‘‘hypo-
glycemia’’ (3 mM glucose), from no activation to near maximal
activation and that in a given cell the time course and magnitude
of responses to multiple pulses of ‘‘hypoglycemia’’ were highly
conserved.
RESULTS
Design of the AMPK Activity Reporter
In order to monitor AMPK activity in living cells, we have de-
signed a genetically encoded fluorescent reporter, AMPKAR,
which is activated in response to phosphorylation by AMPK.
AMPKAR was constructed analogously to a previously reported
protein kinase A reporter, AKAR3 (Allen and Zhang, 2006). To
produce an AMPK reporter, the AKAR3 template was modified
within its substrate phosphorylation sequence in order to create
a site optimized for both the favorable substrate motif for AMPK
obtained from a positional scanning peptide library screen (Turk
et al., 2006) and its subsequent recognition by the phospho-
threonine-binding domain FHA1 (forkhead-associated domain1)
from the yeast rad53p protein (Durocher et al., 2000). Our
positional scanning peptide library approach revealed that
AMPK has a strong selection for Leu at +4, Met or Leu at 5,
and for Arg at 3 or 4. We avoided using Leu at 5 to reduce
the possibility that the site would be phosphorylated by protein
kinase D family members (which have a similar selectivity to
AMPK but prefer Leu over Met at 5) (Hutti et al., 2004). After
testing multiple versions of candidate motif sequences,
MLRVATLVDL, MLRVASLVDL, MLRNATLVDL, MLHRATLVDL,
and MRRVASLVDL (data not shown), we observed an optimal
dynamic range of response using the motif MRRVATLVDL. The
resulting AMPKAR reporter protein consists of the FRET pair
eCFP and circularly permuted variants of Venus cpV E172 (Nagai
et al., 2004), bracketing an FHA1 domain and an AMPK substrate
motif (Figure 1). Phosphorylation of the AMPK substrate withinCthe reporter drives its binding to the FHA1 module resulting in
the juxtaposition between the donor (eCFP) and acceptor (YFP
variant Venus) fluorophores resulting in fluorescence resonance
transfer (FRET).
AMPKAR Reports Endogenous AMPK Activity
in Live Cells
To test whether AMPKAR is able to report endogenous AMPK
activation, we expressed AMPKAR in COS-7 cells and moni-
tored the FRET ratio change after addition of 20mM2-deoxyglu-
cose (2-DG), a glucose analog that inhibits glycolysis and lowers
ATP levels. During the first couple ofminutes after 2-DG addition,
there was a sharp decline in the FRET ratio (Figure 2A), presum-
ably due to a change in osmolarity (a similar drop in FRET ratio
occurs upon adding L-glucose [Figure S1 available online] and
was also observed when the substrate peptide phosphorylation
site was mutated from threonine to alanine [Figure 2C]). After the
decline, we detected a gradual and steady increase in FRET
signal that reached a maximum (17.9% ± 1.5%, average ± stan-
dard error, n = 32) approximately 15 min after 2-DG addition.
Isoelectric focusing of AMPKAR indicates that a 20% increase
in FRET correlates with about 40% phosphorylation (data not
shown). The response observed with our AMPK sensor was
consistent with results obtained in parallel experiments with
western blot analysis with antibodies directed against the known
cellular AMPK substrate, phosphoserine 79 in Acetyl-CoA
carboxylase (pACC Ser79), as well as with high-performance
liquid chromatography (HPLC) measurement of intracellular
AMP:ATPratio, asshown inFigure2BandFigureS2, respectively.
Phosphorylation of AMPK on Thr-172 leads to its activation
and is catalyzed by at least two distinct upstream kinases, the
tumor suppressor LKB1 (Shaw et al., 2004; Woods et al., 2003)
and CaMKKb (Hawley et al., 2005; Hurley et al., 2005; Woods
et al., 2005). To test whether AMPKAR can report signals medi-
ated via CaMKKb, we treated AMPKAR expressing Cos-7 cells
with the calcium ionophore ionomycin. As shown in Figure 2B,
treatment with ionomycin resulted in a maximal response
(37.8% ± 2.2%, n = 15) within 3 min. The AMPKAR- FRET
response to ionomycin was more rapid and transient than that
observed after 2-DG stimulation. These results were consistent
with those of parallel western blot analysis with antibodies
directed against pACC Ser79.
Interestingly, we observed differences in the location of AMPK
activation in response to 2-DG versus ionomycin. As shown in
Figure 2A, the activation in response to 2-DG occurred within
the cytosol, mainly within the perinuclear region. In contrast,
calcium ionophore elicited activation was more widespread
(Figure 2B).
AMPKAR FRET Responses Are Specific to AMPK
To determine whether the production of the FRET signal in
response to AMPK activators was due to phosphorylation at
the threonine within the AMPK substrate motif site, we mutated
this residue to an alanine and tested the response of mutant
AMPKAR-T/A. COS-7 expressing AMPKAR-T/A did not show
a change in the FRET signal in response to either 20 mM 2-DG
or 1 mM ionomycin (Figure 2C), suggesting that the observed
change in the FRET signal indeed results from phosphorylation
at the designed AMPK phosphorylation site.ell Metabolism 13, 476–486, April 6, 2011 ª2011 Elsevier Inc. 477
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Figure 2. AMPKAR FRET Response to Energy Stress and Calcium Elevation
(A) COS-7 cells expressing AMPKAR were treated with 20 mM 2-DG. Left: mean normalized (Y/C) emission ratio (n = 32). Middle: representative pseudocolor
images of Y/C ratio show the FRET response. Right: western blots showed comparable time course for AMPK activation indicated by an increase in phospho-
ACC (S-79) and the corresponding phospho-AMPK (T-172) levels.
(B) COS-7 cells transfected with AMPKAR were treated with 1 mM ionomycin. Left: mean normalized (Y/C) emission ratio (n = 15). Middle: representative
pseudocolor images of Y/C ratio show the FRET response. Right: western blots showed comparable time course for AMPK activation indicated by increase of
phospho-ACC (S-79) and the corresponding phospho-AMPK (T-172) levels.
(C) T to A mutation in the substrate peptide phosphorylation site abolishes FRET. Left: COS-7 cells expressing either AMPKAR(T) (n = 30) or mutant AMPKAR(A)
(n = 8) were treated with 20 mM 2-DG. Right: Cos-7 cells expressing either AMPKAR(T) (n = 14) or mutant AMPKAR(A) (n = 18) were treated with 1 mM ionomycin.
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A Cellular Energy Stress SensorConsidering the similarity among the optimal substrate motifs
of PKA, PKC, PKD, and AMPK family members, next we exam-
ined whether activation of PKA, PKC, or PKD would cause any
signal changes detected by AMPKAR. COS-7 cells expressing
either AMPKAR or a reporter for protein kinase D (DKAR) (Kunkel478 Cell Metabolism 13, 476–486, April 6, 2011 ª2011 Elsevier Inc.et al., 2007) or a reporter for PKA (AKAR3) (Allen and Zhang,
2006) were stimulated with 200 nM phorbol myristate acetate
(PMA) to activate PKC and PKD family members or 50 mM for-
skolin to activate PKA, and FRET responses were monitored.
DKAR undergoes a decrease in FRET signal in response to
Figure 3. AMPKAR FRET Signal Is AMPK Dependent
(A) The AMPKAR FRET response is not observed in mouse embryonic fibroblasts that lack AMPK. MEFs lacking both AMPK-a1 and a2 (DKO) or DKO cells
reconstituted with AMPK a2 subunit (a2) were treated with either 20 mM 2-DG (left) (DKO, n = 6; a2, n = 11) or 1 mM ionomycin (right) (DKO, n = 4; a2, n = 13).
Data are presented as mean ± standard error. All drugs were added at time zero.
(B) Western blots of DKO versus a2 MEF treated under the same conditions as those used in the imaging experiments.
(C) The AMPKAR FRET response to energy stress requires LKB1. AMPKAR FRET signals were compared between HeLa cells reconstituted with LKB1
(HeLa_LKB1) or vector (HeLa_vector). Cells were treated with either 20 mM 2-DG or 1 mM ionomycin. Data are presented as mean ± standard error.
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A Cellular Energy Stress Sensorphosphorylation by protein kinase D and, as shown in Figures
S3A and S3B, cells expressing DKAR exhibited a decrease in
FRET when treated with PMA, consistent with PKD activation.
Cells expressing AKAR3 exhibited an increase in FRET in
response to forskolin, consistent with PKA activation. However,
neither PMA nor forskolin induced a FRET response in cells ex-
pressing AMPKAR. These results indicate that AMPKAR is not
an in vivo substrate for PKA, PKC, or PKD family members.
To determine whether the AMPKAR FRET response requires
AMPK, we used mouse embryonic fibroblasts (MEFs) derivedCfrom AMPK knockout mice (Laderoute et al., 2006). We ex-
pressed AMPKAR in AMPK a1 and a2 double knockout (DKO)
MEFs or in DKO MEFs in which the a2 subunit (a2) of AMPK
had been reintroduced (Figures 3A and 3B). As expected,
western blots revealed that phosphorylation of ACC and AMPK
in response to either 2-DG or the calcium ionophore, ionomycin
were observed in reconstituted a2 MEFs (a2) but not in AMPK
DKO cells. Likewise, the AMPKAR-FRET signal change was de-
tected in AMPK a2 reconstituted MEFs but not in DKO MEFs.
Taken together, these results strongly indicate that AMPKAR isell Metabolism 13, 476–486, April 6, 2011 ª2011 Elsevier Inc. 479
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A Cellular Energy Stress Sensora selective reporter of AMPK activity under these stimulation
conditions.
We next asked whether the AMPKAR FRET response to 2-DG
and ionomycin are dependent on the expected upstream
kinases. LKB1 has been shown to be required for activation of
AMPK in response to 2-DG and other agents that lower the
ATP/AMP ratio, while CaMKKb has been shown to mediate
calcium-dependent activation of AMPK. We expressed
AMPKAR in HeLa cells, which are deficient in LKB1 and found
that the FRET response to ionomycin was maintained, but that
the response to 2-DG was defective (Figure 3C). Expression of
LKB1 in HeLa cells restored the AMPKAR FRET response to
2-DG but had no effect on the response to ionomycin. These
results further validate AMPKAR as an in vivo AMPK response
indicator.
Characterization of Subcellular AMPK Activity
Next, we were interested in determining whether AMPKAR could
be used to monitor AMPK activity in distinct cellular compart-
ments. To measure AMPK activity exclusively in the cytosol or
nucleus, we attached either a nuclear export signal (NES) or
nuclear localization signal (NLS), respectively, to the C terminus
of AMPKAR (Figure 4A). The NES-tagged reporter localized to
the cytosol and the NLS-tagged reporter localized to the
nucleus, as expected. Addition of 1 mM ionomycin induced
a FRET response in both NES- and NLS-tagged AMPKARs,
and, interestingly, the cytosolic response from NES-tagged
AMPKAR was of greater magnitude (32.8% ± 1.9%, n = 20
versus 20% ± 2.0%, n = 27) and occurred more rapidly (time
to reach 50% maximal response of <1 min versus 2.5 min)
(Figure 4B). The AMPKAR-FRET signal changes elicited from
addition of either 20 mM 2-DG or 2 mM AICAR were almost
exclusively confined to the cytosolic compartment (Figures 4C
and 4D). This interesting observation is in agreement with
previous reports showing that LKB1 activation takes place
predominantly in the cytoplasm, after it complexes with STRAD
(STE-related adaptor) and MO25 (mouse protein 25) (Boudeau
et al., 2003; Dorfman and Macara, 2008; Hawley et al., 2003).
AMPKAR Senses Intracellular Energy Stress in a Timely
and Reversibly Fashion
We next examined whether AMPKAR can reversibly and dynam-
ically report the energy status of living cells in response to amore
physiological or pathophysiological alteration in nutrient avail-
ability. To address this question, we designed a microfluidic
cell culture system (Figure S4) to examine AMPKAR signals in
real time in response to altered extracellular glucose.
COS-7 cells expressing either AMPKAR or an intracellular
glucose reporter, FLII12Pglu-700uDelta6 (Takanaga et al.,
2008), were cultured in microfluidic channels and a controlled
flow of DMEM media with a varied glucose concentration was
passed over the cells. Interestingly, cells responded rapidly to
alterations in extracellular glucose concentration. As shown in
Figure 5, when the glucose concentration in the medium drop-
ped from 25mM to 0mM, the signal change from the intracellular
glucose sensor was detectable within 1 min and reached
a plateau in less than 3 min (20.0% ± 3.4%, n = 10). Notably,
the AMPKAR FRET signal increased rapidly with only about
a 1 min lag after the drop in cellular glucose. When the glucose480 Cell Metabolism 13, 476–486, April 6, 2011 ª2011 Elsevier Inc.in the medium was restored to 25 mM, cellular glucose levels
returned to normal within approximately 5 min and the AMPKAR
FRET signal dropped to basal level with only a slight lag. These
results indicate that in these cells, cytosolic glucose levels and
ATP/AMP ratios (as judged by AMPK activity) are dynamically
controlled by extracellular glucose. These results also indicate
that AMPKAR is rapidly dephosphorylated when AMPK activity
drops.
AMPKAR Reveals the Similarity and the Variation
of Cellular Energy Stress Responses
Heterogeneity among individual cells is a common feature of
dynamic cellular processes. To better understand how heteroge-
neity contributes to the overall tissue level phenotype, it is impor-
tant to know which properties of the response vary from cell to
cell and which are robust between cells (Spencer et al., 2009).
Using U2OS cells stably expressing AMPKAR, we examined
cell variability in AMPK activation in response to energy stress.
Energy stress was induced with a microfluidics device to cause
an acute change in glucose from 25mM in normal media to either
0 mM or 3 mM (Figure S4). In response to complete withdrawal
of glucose, all the cells examined exhibited an increase in the
AMPKAR FRET signal, though the half time for response and
magnitude of response was variable from cell to cell (Figure 6A).
When glucose was replenished by switching back to regular
media with 25mMglucose, the signal promptly returned to basal
level. When treated with a second pulse of 0 glucose, each cell
responded in a similar fashion to the first pulse.
When cells were shifted from 25 mM glucose to a more phys-
iologically relevant level of ‘‘hypoglycemia’’ (3 mM glucose) there
was a greater cell-to-cell variability AMPKAR FRET response.
Twenty-three percent (six out of 26) of the cells failed to respond
to this more modest stress, while a few cells showed a near
maximum response (Figure 6B). Interestingly, all cells that re-
sponded to the first pulse also responded to the second pulse.
No increase in AMPKAR FRET signal was observed in the control
channel, in which cells were perfused with medium with
a constant 25 mM glucose concentration.
To quantify the variability in the dynamics, we measured
several parameters of the response profile to both pulses of
glucose starvation for each cell, including the half times for
the increase (T1/2up1,T1/2up2) and decrease (T1/2d1,T1/2d2)
phases for each pulse, and the maximal response amplitude
(AmpMax1,AmpMax2); see Figure 6C for definitions. To measure
cell-cell variability, we used the coefficient of variation (CV),
defined by the ratio of the standard deviation to the mean
(CV = SD/mean), as shown in Figure 6D.
When cells were exposed to modest stress with physiologi-
cally relevant ‘‘hypoglycemia’’ with 3 mM glucose, the maximal
amplitude (AmpMax) of response showed a large variation among
cells (CV = 64%–69%). In contrast, two of the temporal parame-
ters showed relatively modest cell-cell variability: around 16%–
20% in T1/2 up and 20%–25% in T1/2 d.
In response to complete glucose withdrawal, there was less
variability in these parameters (Figure 6D). Not surprisingly, cells
responded faster (mean ± SE: T1/2 up1: 4.12 ± 0.20 min versus
4.84 ± 0.22 min, p = 0.02) and more strongly (AmpMax:
31.0% ± 1.9% versus 11.8% ± 1.4%, p = 6.88E–10) to harsh
stress (zero glucose) than to modest stress (glucose 3 mM).
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Figure 4. Subcellular Targeting of AMPKAR
(A) Schematic domain structures of nuclear and cytosol targeted AMPKAR. The asterisk represents the localization of the AMPK substrate motif. YFP
fluorescence image of AMPKAR-NLS (left) or AMPKAR-NES expressing C2C12 cells.
(B) Representative emission ratio time course of cytosolic (cy, n = 20) versus nuclear targeted AMPKAR in response to 1 mM ionomycin (nu, n = 27).
Data are presented as mean ± standard error.
(C) Representative emission ratio time course of cytosolic (cy, n = 5) versus nuclear (nu, n = 16) targeted AMPKAR in response to 20 mM 2-DG treatment.
Data are presented as mean ± standard error.
(D) Representative emission ratio time course of cytosolic (cy, n = 6) versus nuclear (nu, n = 19) targeted AMPKAR in response to 1 mM AICAR treatment.
Data are presented as mean ± standard error. All drugs were added at time 0 as indicated by arrows.
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A Cellular Energy Stress SensorHowever, there was no significant difference in the recovery
time for the two stresses (T1/2 d 2.82 ± 0.15 min versus 2.81 ±
0.16 min, p = 0.96). Importantly, comparing cellular responses
of two episodes of stimulation from the same strength of stress,
we found that there is no significant difference between the two
pulses in either the amplitude or the time parameters (Figure 6E),
suggesting that on this time scale, the cell characteristics that
provide the variability in homeostatic response to glucose
withdrawal do not significantly change.CDISCUSSION
The fluorescent biosensor AMPKAR presented here represents
a novel tool for monitoring AMPK activity in living cells. In
comparison with the existing methods for measuring AMPK
activation, AMPKAR offers many advantages. It provides infor-
mation that is consistent with biochemical approaches, yet
with greater spatiotemporal resolution at both the single cell
and cell population levels. We showed that the enhancedell Metabolism 13, 476–486, April 6, 2011 ª2011 Elsevier Inc. 481
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Figure 5. AMPKAR Exhibits Reversible Dynamics
(A) Manipulating extracellular glucose concentrations leads to reciprocal changes of FRET signals from AMPKAR and ICGS (intracellular glucose sensor
FLII12Pglu-700uDelta6). COS-7 cells were transfected with either AMPKAR (right) or ICGS (left) and seeded on themicrofluidic devices. Cells were perfused with
a continuous flow of regular DMEMwith 25 mM glucose for 4 min (time points 1–5), switched to glucose free DMEM (G = 0) for 20 min, and then switched back to
regular DMEM with 25 mM glucose (G = 25). Each frame shows the FRET ratio at 1 min intervals (left to right and top to bottom).
(B) Tracings of the AMPKAR FRET response (squares; average from 30 cells) and ICGS FRET response (circles; average from ten cells) from cells treated as
described in (A). The AMPKAR FRET signal from the control in which cells were continuously exposed to a flow of 25 mM glucose throughout the time course is
also presented (triangles; averaged from seven cells).
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A Cellular Energy Stress SensorAMPKAR FRET signal in response to energy stress or cytosolic
calcium elevation depends on the presence of AMPK in the
cell, indicating that AMPKAR is a good reporter of AMPK activity
in responses to these stimuli. We also showed that AMPKAR
does not respond to stimuli that activate PKA, PKC, and PKD
family members. It is possible that AMPKAR is phosphorylated
by the MARK (microtubule affinity-regulating kinase) family of
protein kinases, which are closely related to AMPK. Our studies482 Cell Metabolism 13, 476–486, April 6, 2011 ª2011 Elsevier Inc.indicate that in response to energy stress or calcium elevation,
the AMPKAR FRET signal is dependent on AMPK activation.
Future studies should reveal whether stimuli that activate any
other signaling pathways including AMPK-related kinases can
also induce an AMPKAR FRET response.
AMPKAR was not only capable of capturing the dynamics of
AMPK activity in real time but also demonstrated spatial varia-
tions in activity elicited by different stimuli. AMPK, its upstream
AB C
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Figure 6. AMPKAR Reveals Cell-to-Cell Variability in Energy Stress Response
(A) AMPKAR reveals cell-cell variations in energy stress response. At time 0, U2OS cells stably expressing AMPKAR were switched from media with 25 mM
glucose tomedia with either 0 glucose (six boxes on left) or 3mMglucose (six boxes on right). After 10min, the cells were shifted back to 25mMglucose, at 20min
they were shifted back to the low glucose, and at 30 min they were shifted back to high glucose. The 12 boxes are representative single cell tracings of cellular
FRET response to the two pulses of ‘‘low glucose.’’
(B) Distribution of maximal AMPKAR FRET response (AmpMAX) from individual cells exposed to 0 (G0) or 3 mM glucose (G3).
(C) Definition of parameters in AMPKAR activity in response to low glucose stimulation. Gw denotes glucose withdrawal and G25 denotes 25 mM glucose in
media. AmpMax denotes the maximal FRET signal (normalized y/c ratio); T1/2up denotes the time to reach half of maximal response (minutes), T1/2d denotes the
time to return to half of maximal fluorescence during FRET decrease (minutes). Subscript 1 and 2 denotes response from first and second pulses, respectively.
(D) Cell-cell variability measured as the CV (coefficients of variance: ratio of standard deviation to mean) of different aspects of cellular response to glucose
starvation. Top: AMPKAR FRET response upon shift to 3 mM glucose (G3). Bottom: AMPKAR FRET response upon shift to zero glucose (G0).
(E) While the median increase in the AMPKAR FRET amplitude is greater upon complete glucose removal compared to partial glucose removal, cells exhibit
a similar response in the second pulse of low glucose to the response in the first pulse, and the half times for the increase and decrease of the FRET signal are
relatively constant. Data are presented asmean ± standard error. g0 denotes zero glucose; g3 denotes 3mMglucose; p1 and p2 denote first and second pulses of
stimulation, respectively. (NS, statistically nonsignificant.)
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A Cellular Energy Stress Sensoractivating kinases and downstream substrates may preferen-
tially reside in distinct subcellular compartments. Targeting
AMPKAR to the nucleus or cytosol provides a readout of
AMPK activity in these locations, and thus facilitates the detec-
tion of a spatial-specific role of AMPK in signal propagation.
For example, AMPK has been reported to control a number of
transcriptional processes as well as epigenetic events (McGee
and Hargreaves, 2008); however, how nuclear AMPK itself is
activated has remained unclear. When we activated AMPK by
the energy stress inducing agent 2-DG, or the AMP mimetic
AICAR, we observed that AMPK activation by LKB1 is largely
localized to the cytosol. In contrast, ionomycin-induced AMPK
activation (presumably mediated by CaMKKb) occurred both in
the cytosol and nucleus. While it has been shown that LKB1 acti-
vation takes place predominantly in the cytoplasm, after it
complexes with STRAD and MO25 (Boudeau et al., 2003; Dorf-
man and Macara, 2008; Hawley et al., 2003), it is still possible
that AMPK is activated in the nucleus under certain conditions
since LKB1 can shuttle between the cytoplasm and the nucleus
(Dorfman and Macara, 2008). Further studies will be necessary
to determine under what conditions, if any, AMPK becomes acti-
vated in the nucleus in response to energy stress.
Signaling cascades propagate information about fluctuations
in the extracellular environment so that cells can respond
accordingly. As an energy sensor, how does AMPK sense and
react to relevant stimuli that encode information about a fluctu-
ating environment? Taking advantage of microfluidic technology
in combination with AMPKAR, we were able to visualize rapid
and reversible cellular responses to the alterations of extracel-
lular glucose and to ask whether individual cells respond differ-
ently to energy stress. We observed that, under modest energy
stress, the timing of response is less variable than the amplitude
of response. This is intriguing since similar results have previ-
ously been reported in other systems, including the ERK
response to EGF (Cohen-Saidon et al., 2009), in p53 oscillations
(Geva-Zatorsky et al., 2006), and circadian oscillations (Mihal-
cescu et al., 2004).When stress ismore severe, however, cellular
responses become faster and stronger, and the cell-to-cell vari-
ations also are smaller. Despite the variability, we also found that
some aspects of the dynamics upon energy stress are very
similar between cells: both the magnitude of response and the
response time are related to the level of the stimuli. Notably,
most cells return to their original basal levels after an initial pulse,
and the peak heights as well as the time to reach maximal
response are similar in two sequential pulses. This kind of adap-
tation behavior could be crucial for AMPK as an energy stress
sensor, allowing it to reset itself and become ready to respond
to the next stimulus in a dynamically changing environment.
During the development of CFP-YFP-based FRET reporters
for adenosine nucleotides, Willemse et al. reported that all of
their FRET constructs had a significant response to millimolar
levels of ATP (Willemse et al., 2007). As the authors pointed
out, this is a cautionary note for ATP interference with all
FRET-based sensors. In the scenario of AMPKAR, it is unlikely
that the signal change we observed was due to dequenching
of the FRET signal resulting from the decrease in ATP levels,
since the FRET signal was abolished when we mutated the
substrate site threonine of AMPKAR to an alanine and was
also abolished upon deletion of both AMPK genes.484 Cell Metabolism 13, 476–486, April 6, 2011 ª2011 Elsevier Inc.In summary, we have designed and characterized a genetically
encoded FRET based biosensor, AMPKAR, to provide a selec-
tive, reversible, and real-time readout of AMPK activity. This
tool offers an opportunity to probe both when and where
AMPK is activated in living cells/tissues, and possibly living
animals, during physiological or pathological conditions. It might
also facilitate AMPK activator drug discovery in high-content
screening. Furthermore, this AMPK response reporter provides
new insight into single cell responses to energy stress that will
be valuable for understanding energy homeostasis.
EXPERIMENTAL PROCEDURES
Materials
Anti-phospho-AMPK (Thr172), anti-AMPK, anti-phospho-ACC and anti-ACC
antibodies were purchased from Cell Signaling Technology. AICAR was ob-
tained from Toronto Research Chemicals (Downsview, ON, Canada). 2-DG
and ionomycin were purchased from Sigma and Cell Signaling Technology,
respectively. AKAR3 and DKAR plasmids were kindly provided by Jin Zhang
and Alexandra Newton, respectively. Intracellular glucose concentration
reporter (FLII12Pglu-700uDelta6) was obtained from Addgene (contributed
by Wolf Frommer Laboratory).
AMPKAR Construction
AMPKAR was engineered by starting with the sequence of the PKA reporter,
AKAR3 and modifying the substrate motif to be optimal for AMPK, based
on previous studies with peptide libraries. Several versions of the sub-
strate sequence were generated, including MLRVATLVDL, MLRVASLVDL,
MLRNATLVDL, MLHRATLVDL, MRRVATLVDL, MRRVASLVDL, and
MRRVAALVDL (T/A mutant) by PCR mutagenesis with QuikChange protocol
(Stratagene). For cytosolic targeting, NES PKKKRKVEDA (Zhang et al., 2001)
was added to the C terminus of Venus in the AMPKAR construct. For nuclear
targeting, three tandem repeats of the SV-40 large T antigen NLS peptide
DPKKKRKVwere fused to the C terminus of Venus. All constructs were verified
by sequencing after subcloning into the pcDNA3.1 vector.
Cell Culture, Transfection, and Generation of Stable Cell Lines
COS-7, C2C12, HeLa cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM; GIBCO) containing 10% fetal bovine serum and 1% peni-
cillin/streptomycin at 37C in 5%CO2. For retroviral transfection, amphotropic
retrovirus were generated as described previously (Zheng and Cantley, 2007).
MEFs were maintained in DMEM containing 10% fetal bovine serum and 1%
penicillin/streptomycin at 37C in 10%CO2. Cells were plated onto fibronectin
coated MatTek dishes prior to transfection. Transient transfection was carried
out using FuGENE 6 (Roche Diagnostics) for COS-7, HeLa, and C2C12 cells,
and Lipofectamine LTX (Invitrogen) for MEFs. Imaging was carried out 18 to
36 hr after transfection. U2OS cells stably expressing AMPKAR were gener-
ated utilizing Gateway recombination cloning technology (Invitrogen). In brief,
AMPKAR was cloned into a lentiviral vector engineered from a pHR backbone
and CMV promoter. Lentiviruses were generated by cotransfecting each
recombined destination vector with packaging plasmid (delta8.9), envelope
protein plasmid (VSV-G) to HEK293T by Fugene 6 (Roche) as recommended
by the manufacturer. Fresh medium was added to the cells 24 hr after
transduction, and 2 mg/ml puromycin was added for selection. The medium
was replaced every 3 days until foci could be identified, and individual foci
were then selected and expanded.
Microfluidic Device Layout Design and Microfabrication
The microfluidic device was designed for rapid switch of the cell culture
medium surrounding cultured cells. This device consists of five microfluidic
channels in which cells were seeded and cultured under constant perfusion
(600 ml/hr) of cell culture medium introduced from two inlets (as shown in Fig-
ure S4). After the cells attached to the substrate (2–4 hr, depending on cell
type), the medium from one inlet was replaced with a medium containing the
desired stimuli to cultured cells. To selectively expose cells to the stimuli,
the position of the interface where the two fluids meet, was adjusted by
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A Cellular Energy Stress Sensorchanging the hydrostatic pressures used for driving the two fluids. For
example, when the hydrostatic pressure driving the stimuli-containing medium
from the right inlet is higher, the interface of the two fluids shifts to the left, cells
in the third channel are exposed to regular medium (Figure S4B). On the other
hand, when the hydrostatic pressure driving the stimuli-containing medium
from the left inlet is higher, the interface of the two fluids shifts to the right,
and glucose free medium flows to the cells in the third channel (Figure S4C).
As a result, cells in each individual channels can be temporally exposed to
the stimuli at will.
Our microfluidic devices were made of Polydimethylsiloxane (PDMS)
(Sylgard 184, Dow Corning, Midland, MI) and glass with soft lithography tech-
niques (McDonald et al., 2000). In brief, negative photoresist (SU-8, Micro-
Chem, Newton, MA) was photolithographically patterned on a silicon wafer
to create a master with microscale features. The heights of SU-8 features
(90 mm) on the master were measured with a surface profilometer (Dektak
ST System Profilometer, Veeco Instruments, Plainview NY). The master was
then used as a mold, on which PDMS prepolymer mixed with its crosslinker
at 10:1 weight ratio was poured, degassed, and allowed to cure in a conven-
tional oven at 65C for 24 hr. The cured PDMS replicas were removed from the
mold, subjected to a brief oxygen plasma treatment, and bonded to glass
substrates to form the final devices.
Glucose Perfusion
For the experiment demonstrating reciprocal change of intracellular glucose
reporter and AMPKAR, cells were perfused with 25 mM glucose for 4 min
(time points 1–5) at the beginning of the experiment to establish a baseline
response. Then glucose-free media was perfused for 20 min to record the
response from intracellular glucose concentration reporter (FLII12Pglu-
700uDelta6) or the response from AMPKAR. Finally, glucose concentration
was switched back to 25 mM for another 10 min. For the experiment of single
cell response variations to glucose starvation, cells on the device were
perfused with regular media containing 25 mM glucose initially as a baseline
condition for 2 min (time points 0–3) and then switch to media containing either
zero or 3 mM glucose for 10 min. Then, glucose was replenished by switching
back to regular media with 25 mM glucose for another 10 min. A second pulse
of ‘‘glucose starvation’’ was again administered, to test whether cells remain
responsive to another episode of energy stress.
Live-Cell Imaging
Cells were plated on either number 1.5 coverslips MatTek Dish (#P35G-1.5-
14-C) or microfluidic devices (see the Supplemental Experimental Procedures
for details). DMEM media (GIBCO) containing 25 mM HEPES, 25 mM glucose
(except for the experiment of manipulating glucose concentration), 2 mM
glutamine, and 3% FBS, (phenol red was excluded during image acquisition).
Cells were imaged on a Nikon TE 2000E and a Nikon and Ti motorized inverted
microscope with 203/0.75 or 603/1.4 (oil immersion) NA objective lens. Dual
emission ratio imaging was performed with a 436/10 filter, a diachronic mirror
(Chroma 86002v1bs), and two emission filters (470/30 for cyan and 535/30 for
yellow). All optical filters were obtained from Chroma Technologies. Images
were acquired with a Hamamatsu ORCA-R2 cooled CCD camera controlled
withMetaMorph 7 software (Molecular Devices) and the Perfect Focus System
for continuous maintenance of focus. Fluorescence images were background-
corrected. For time-lapse experiments, images were collected every 30–60 s,
with an exposure time of 50–100 ms and 232 binning, with illumination light
shuttered between acquisitions. The ratios of yellow-to-cyan were then
calculated at different time points and normalized by dividing all ratios by
the emission ratio before stimulation, setting the basal emission ratio as 1.
Western Blotting
Cell lysates were prepared with lysis buffer containing HEPES (pH 7.0),
150 mM NaCl, 1% NP-40, 1 mM EDTA, 50 mM NaF, 10 mM b-glycero-phos-
phate, 10 nM calyculin A, 1 mM Na3VO4, and protease inhibitors and normal-
ized by protein concentrations using the Bradford method (Bio-Rad). For
western blotting, protein samples were separated on 8%–12% SDS-PAGE
and transferred to PVDF membranes (Millipore). Membranes were blocked
in TBST containing 5% nonfat milk, incubated with primary antibodies accord-
ing to the antibody manufacturer’s instructions, followed by incubation withChorseradish peroxidase-conjugated goat anti-rabbit or anti-mouse IgG
(Chemicon) and enhanced chemiluminescence detection (Perkin Elmer).
Measurement of ATP and AMP in 2DG-Treated COS7 Cells by HPLC
COS7 cells were treated with or without 2DG for the indicated time and lysed
with 10% HClO4. The nucleotide-containing fraction was purified by mixed
phase extraction employing 11.75:13.25 (vol/vol) of tri-n-octylamine (Sigma)
and Freon 11 (Sigma). HPLC was performed as described previsouly
(Budinger et al., 1996) with Agilent Technology 1200, a Zorbax Rx-C8 column
(43 250mm), buffer A; 50mMKH2PO4, 8 mM tetrabutylammonium hydrogen
sulfate (TBAS), and 40% (vol/vol) acetonitrile at pH 5.8, Buffer B; 50 mM
KH2PO4, 8 mM TBAS at pH 5.8. The nucleotides were detected
spectrophotometrically.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at doi:10.1016/j.cmet.2011.03.006.
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